Since it was reported that the frequency of TP53 mutation was high in TNBC (Network, 2012), it was consistent with our finding that the expression of CHAF1A was not only higher in TP53 mutant breast cancer, but also higher in TNBC. This evidence concerns the gene TP53 and breast cancer.